Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 May 2023 | Story Tobias van den Bergh

During May this year, the University of the Free State Department of Student Counselling and Development (SCD) invites all staff and students to play an active part in their own mental health. Every day. You can do one small thing each day towards better mental health. That is why the campaign is called DoDay – do something today and make it a do day. 
Remember that maintaining mental well-being is like brushing your teeth, so we recommend it daily!

For 30 days, doable mental health activities will be shared on the SCD Instagram and Facebook pages. You will be invited to participate in the activity and share your experience online. We encourage you to take up the challenge and share the skills for better mental health. 

Be successful
As we approach the mid-year exams where staff and students experience added pressure and anxiety, it is the perfect time to dedicate 10 to 15 minutes daily to your mental health. Each week, we will focus on five different mental health building blocks: social wellness, emotional wellness, intellectual wellness, physical wellness, and spiritual wellness. By participating in the different activities each day, you will cover all the different wellness areas. 

Be informed
During the campaign, we will also release insightful podcast interviews with experts who share their personal and professional experiences of each wellness area. It is no secret that communities are stronger together. Let us all work towards collectively improving our mental well-being and supporting one another on this journey. 

Be happy
Improved mental health supports your professional and academic performance. It also helps you to make better decisions and enjoy life more. Improving your mental well-being has never been easier than following the DoDay calendar. You will receive clear guidelines on what to do each day, and you can mark off your progress and share your activities as you go. 

Be a DoDayer

Remember that maintaining mental well-being is like brushing your teeth, so we recommend it daily! Join the UFS Mental Health DoDay drive and take one small daily action for 30 days towards better mental health. Download your 30-day DoDay calendar here and remember to share and inspire others on Instagram. Make every day a Mental Health DoDay!

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept